5 questions on CRISPR-Cas with Sandeep Rajan

2026-09-01T08:46:22+01:001 September 2026|

From bacterial defence to breakthrough therapies, we explore how CRISPR-Cas is transforming research and healthcare, and how experts at the Wellcome Sanger Institute are refining the technology to make genome editing more scalable and effective.

Five questions with… Professor Matt Hurles on rare disease research

2025-02-28T09:34:53+00:0028 February 2025|

In celebration of Rare Disease Day, we caught up with Matt Hurles, Director and Senior Group Leader at the Wellcome Sanger Institute, to reflect on the importance of raising awareness of rare diseases and how our work at the Institute is supporting this community by accelerating our progress in the genomics space.

Nine billion and counting – Mapping the human variants and their effects on health and disease

2024-05-15T13:42:40+01:0016 January 2024|

The Atlas of Variant Effects Alliance celebrates its fourth year this month.  A collaboration of multiple institutes, including the Wellcome Sanger Institute, the Alliance has the aim of assessing the effects of all variants in our genomes. In this blog, we highlight the Alliance’s achievements and the diverse community underpinning such a colossal effort.